Saliva as a Window Into Cystic Fibrosis: Metabolic Biomarkers and Clinical Potential

https://is1-ssl.mzstatic.com/image/thumb/Podcasts125/v4/59/78/46/5978466f-c037-d8d9-8184-8d243ecbb02b/mza_11747583196739505678.jpg/600x600bb.jpg

Conference Coverage

ReachMD

287 episodes

5 days ago

ReachMD brings you the latest research, announcements, and conversations from the most important medical conferences around the world. Join us on the conference floor with keynote speakers, experts, and opinion leaders.

Science

Medicine

RSS

All content for Conference Coverage is the property of ReachMD and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.

Science

Medicine

Saliva as a Window Into Cystic Fibrosis: Metabolic Biomarkers and Clinical Potential

Conference Coverage

3 weeks ago

Saliva as a Window Into Cystic Fibrosis: Metabolic Biomarkers and Clinical Potential

Host: Ryan Quigley

In a 2025 study investigating salivary metabolites as potential biomarkers in cystic fibrosis, researchers identified distinct metabolic patterns linked with key complications as well as correlations with lung function. In this AudioAbstract, Ryan Quigley discusses how a simple saliva sample could provide clinicians with an accessible, non-invasive tool to stratify patients, monitor therapies, and advance personalized care in cystic fibrosis. This topic was also discussed at the 2025 CHEST Annual Meeting.